glp 1 and b12 deficiency Nutritional deficiencies muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study GLP-1 with Vitamin B12 |
Description
GI, muscle, and bone side effects are some known risks that must be weighed when starting incretin therapy
JPML has created a new multidistrict litigation for lawsuits alleging that GLP-1 receptor agonist drugs cause NAION, a serious vision injury.
Third-party tested potency, heavy metals, microbials
Shop All THRIVE products
Conclusions To conclude, reduced Cmax and delayed tmax of drugs co-administered with GLP1RAs are consistent with the known delayed gastric output by the latter
Case presentation Four male patients were diagnosed with NAION during semaglutide treatment, with treatment durations of less than one year in three cases
